Recurrent

19 registered clinical trials studyying Recurrent — 9 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Electroacupuncture for the Prevention of Recurrent Lower Urinary Tract Infection in Women NCT07507851	Yanjun Zhang, Baoyan Liu	N/A
Not Yet Recruiting	A Phase II Study of Utidelone With Toripalimab in Advanced Cervical Cancer NCT07363330	Zhongnan Hospital	Phase 2
Recruiting	Autologous CAR-T Cells Targeting B7H3 in Ovarian Cancer iC9-CAR.B7-H3 T Cells NCT06305299	UNC Lineberger Comprehensive Cancer Center	Phase 1
Recruiting	Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC NCT06096038	UNC Lineberger Comprehensive Cancer Center	Phase 1 / Phase 2
Recruiting	Cervical Cancer Oligo States (Recurrence, Metastasis) Multicentre Outcomes Study. NCT07400809	Tata Memorial Hospital	—
Recruiting	A Study of Lorlatinib in Combination With Ramucirumab in People With Lung Cancer NCT06007937	Memorial Sloan Kettering Cancer Center	Phase 1 / Phase 2
Completed	Bovine Colostrum for Prophylaxis Against Recurrent Urinary Tract Infection in Children NCT06164600	Ain Shams University	Phase 2
Not Yet Recruiting	Re-irradiation Therapy of Locally Recurrent Rectal Cancer With Carbon Ion NCT05807984	Xin Cai	Phase 2
Recruiting	Partial Breast Re-irradiation in Women in Women with Locally Recurrent Breast Cancer Previously Treated with C NCT05772390	Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS	Phase 2
Completed	3-point With 1-point Mesh Fixation in TAPP for Inguinal Hernia NCT06314152	Nanchong Central Hospital	N/A
Unknown	NK Cell Therapy Recurrent/Refractory Elderly AML NCT04599452	The Second Hospital of Shandong University	Phase 1 / Phase 2
Recruiting	Association Between Exercise, Patient-Reported Outcomes, and Clinical Events in Adult Cancer Survivors NCT07030686	Memorial Sloan Kettering Cancer Center	—
Completed	DPX-Survivac and Checkpoint Inhibitor in DLBCL NCT03349450	Sunnybrook Health Sciences Centre	Phase 2
Active Not Recruiting	"Re-Stimulated" TILs and IL-2 Therapy for Platinum Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Ca NCT01883297	University Health Network, Toronto	Phase 1
Completed	A Study of Drug Therapies for Salivary Gland Cancers Based on Testing of Genes NCT02069730	University Health Network, Toronto	N/A
Completed	The Effects and Mechanisms of Mindfulness Based Cognitive Therapy (MBCT) on Depressive Symptoms and Depression NCT01145872	University of Denver	Phase 3
Unknown	Adjuvant Intravitreal Bevacizumab in Pars Plana Vitrectomy for Diabetic Vitreous Hemorrhage NCT01151722	University of Sao Paulo	Phase 2
Unknown	Weekly Docetaxel Plus Cisplatin or Oxaliplatin for AGC NCT00510107	Gachon University Gil Medical Center	Phase 2
Unknown	Treatment Result of KTP Laser Nasopharyngectomy in Recurrent NPC Patients NCT00364962	National Taiwan University Hospital	—